Real-world use of biomarkers for Parkinsonism: Should I do this (pSyn) or DaT?
Objective: To examine the utility of commercially available skin phosphorylated alpha-synuclein deposition test (pSyn) in patients with clinically ambiguous parkinsonism and its concordance with dopamine…Comparison of Composite Method Calculations for Monitoring Disease Progression in Early Parkinson’s Disease
Objective: Objective: To evaluate the influence of composite scoring methodologies using digital measures of gait, tremor, and bradykinesia to monitor disease progression over one year…Subthalamic Nucleus Stimulation Modulates Cognitive Theory of Mind in Parkinson’s Disease
Objective: This study aims to investigate the effect of subthalamic nucleus (STN) deep brain stimulation (DBS) on ToM using the Parkinson’s disease (PD) model. Background:…Misdiagnosis of Cognitive Impairment in Parkinson’s disease
Objective: We explored potential bias to diagnose cognitive impairment in People with Parkinson’s (PwP) followed in the Parkinson’s Progressive Markers Initiative (PPMI). Background: In primary…Investigating an Emerging Anxiety-like Phenotype in a Novel Bilateral Rodent Model of Parkinsonian Alpha-Synuclein Pathology
Objective: Investigate an emerging anxiety-like phenotype at various timepoints in a novel bilateral rodent model of parkinsonian alpha-synuclein pathology. Background: Parkinson’s Disease (PD) anxiety poses…Dysphagia is Frequent in early Parkinson´s Disease. Results from a 5-year Follow-up Study.
Objective: The aim of the present study was to analyze the frequency of dysphagia in patients with early Parkinson´s disease (PD) and to compare with…Speech features in Korean Parkinson’s disease patients: A prospective cohort study
Objective: In this study, we explored speech characteristics of Korean Parkinson's disease (PD) patients and their usefulness as a biomarker. Background: Previous studies have shown…Clinical and Neuroimaging Biomarker Predictors of Autonomic Dysfunction in Parkinson’s Disease: A Study Using PPMI Data
Objective: To evaluate whether clinical and neuroimaging baseline markers predict the onset of significant dysautonomia over five years in individuals with idiopathic, de novo Parkinson's…Beyond constipation: gastrointestinal phenomena in Parkinson’s disease
Objective: To describe the prevalence of gastrointestinal manifestations in patients with Parkinson's disease in a Brazilian movement disorders outpatient clinic and evaluate their associated factors…Exploring the Influence of Sleep Disorders on Speech Intensity in Individual’s with Parkinson’s Disease
Objective: This study aimed to examine the impact that sleep disorders and disturbances have on speech intensity in individuals with Parkinson’s disease (PD). Background: PD…
- « Previous Page
- 1
- …
- 179
- 180
- 181
- 182
- 183
- …
- 436
- Next Page »